After buying Cyclica and Valence, Recursion secures $50 million USD from Nvidia for drug discovery
Chip giant Nvidia has invested $50 million USD in Recursion to fuel the development of its AI for drug-discovery tech, as part of a deal that will see the two US firms collaborate.
Source: betakit.com